Fibromyalgia: Pregabalin for the Treatment of Fibromyalgia
On June 21, 2007, the Food and Drug Administration approved the use of Lyrica for the treatment of fibromyalgia. Historically, this is a big first step in helping healthcare professionals have a viable, proven, treatment option for this illness. Following is an article by Dr. Patrick Wood, a published fibromyalgia researcher, describing the scientific research on this medication and the resulting recommended use of Lyrica in this patient population.
Rae Marie Gleason
Patrick B. Wood, MD
On June 21, 2007, the U.S. Food and Drug Administration (FDA) announced its approval of pregabalin (Lyrica